Stevanato Group
Develops pharmaceutical containment, delivery, diagnostic, and manufacturing solutions for drug-development and production workflows.
$21.15
After-hours close+0.07 (+0.33%)
At close$21.08(−5.47%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.17 | — | — |
| Aug 2026 | $0.14 | $0.16 | +10.5% |
| May 2026 | $0.12 | $0.13 | +8.3% |
| Mar 2026 | $0.20 | $0.21 | +5.0% |
| Nov 2025 | $0.14 | $0.16 | +14.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | $0.17 | — | — | $374.5M | — | — |
| Aug 4, 2026 | $0.14 | $0.16 | +10.5% | $340.6M | $344.9M | +1.3% |
| May 7, 2026 | $0.12 | $0.13 | +8.3% | $310.5M | $316.1M | +1.8% |
| Mar 4, 2026 | $0.20 | $0.21 | +5.0% | $391.3M | $407.0M | +4.0% |
| Nov 6, 2025 | $0.14 | $0.16 | +14.3% | $385.5M | $355.1M | −7.9% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 6, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Oct 31, 2023 | ||||||
| Jul 28, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 8, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 19, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||